Baudax Bio, Inc (BXRX): Warning Signs Ahead – A Trap?
Apparently, Baudax Bio, Inc (NASDAQ: BXRX)) refers to a pharmaceutical company that intends to develop and market products for acute care settings. The company brings the optimum level solutions to patients, healthcare providers for its therapeutic options. Last year, FDA has approved its renowned product ANJESCO for moderating severe pain in its patients. It seems […]
Baudax Bio, Inc (BXRX): Warning Signs Ahead – A Trap? Read More »